[Meta] the compounding rule is doing its job and people should stop complaining
telehealth. That is the whole post, but I will justify it.
Everything else people worry about in c/coldchain is downstream of it. Titration speed, reflux, the endless dose arguments — most of it resolves if you sort telehealth out first, and almost nobody does.
I say this having got it wrong for 2 months. My fasting insulin was the thing that eventually made me pay attention, which is a stupid way to learn a lesson that was in the sidebar the whole time.
best — the order this archive was captured in
Are we talking 503A or 503B?
telehealth prescriber models exist, pricing differs by state
regulatory claims need a citation to the actual rule, not interpretation
Strongly agree. API source transparency matters.
the the UK situation is different from the US, different regulations
Small correction: the trial was 3 weeks, not 13. Does not change your point but people will quote it.
regulatory claims need a citation to the actual rule, not interpretation
Mechanistically the bit that matters is 503A. It explains most of the early profile and a decent chunk of the outcome.
Respectfully this is a sample of one presented as a finding.
- 1Are we talking 503A or 503B?8 comments in this branch · started by u/hugo_bergstrom